Impact of viral eradication with sofosbuvir‐based therapy on the outcome of post‐transplant hepatitis C with severe fibrosis
Impact of viral eradication with sofosbuvir‐based therapy on the outcome of post‐transplant hepatitis C with severe fibrosis is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Impact of viral eradication with sofosbuvir‐based therapy on the outcome of post‐transplant hepatitis C with severe fibrosis have?
Impact of viral eradication with sofosbuvir‐based therapy on the outcome of post‐transplant hepatitis C with severe fibrosis has 45 citations in the OpenAlex counts ScholarIQ stores.
When was Impact of viral eradication with sofosbuvir‐based therapy on the outcome of post‐transplant hepatitis C with severe fibrosis published?
Impact of viral eradication with sofosbuvir‐based therapy on the outcome of post‐transplant hepatitis C with severe fibrosis has 2016 year in the ScholarIQ index.
What is the open-access status of Impact of viral eradication with sofosbuvir‐based therapy on the outcome of post‐transplant hepatitis C with severe fibrosis?
Impact of viral eradication with sofosbuvir‐based therapy on the outcome of post‐transplant hepatitis C with severe fibrosis has green oa status in the ScholarIQ index.
What is the DOI of Impact of viral eradication with sofosbuvir‐based therapy on the outcome of post‐transplant hepatitis C with severe fibrosis?
The DOI for Impact of viral eradication with sofosbuvir‐based therapy on the outcome of post‐transplant hepatitis C with severe fibrosis is on the source record.
What is the PMID of Impact of viral eradication with sofosbuvir‐based therapy on the outcome of post‐transplant hepatitis C with severe fibrosis?
The PMID for Impact of viral eradication with sofosbuvir‐based therapy on the outcome of post‐transplant hepatitis C with severe fibrosis is on the source record.
What is the OpenAlex record for Impact of viral eradication with sofosbuvir‐based therapy on the outcome of post‐transplant hepatitis C with severe fibrosis?
The OpenAlex for Impact of viral eradication with sofosbuvir‐based therapy on the outcome of post‐transplant hepatitis C with severe fibrosis is on the source record.